MUMBAI, India, July 31 -- Intellectual Property India has published a patent application (202541004199 A) filed by Curateq Biologics Private Limited on January 17, 2025, for Anti-Il17 Antibody Formulations.
Inventors include Meyyappan, Arumugam; Chhatbar, Chandresh; and Dadke, Disha.
The application for the patent was published on July 24, 2026, under issue no. 30/2026.
Abstract: The present disclosure relates to the field of pharmaceutical products, and in particular relates to anti-IL17 antibody formulations and the processes of making such pharmaceutical products, more particularly, the present disclosure relates to antibody formulation comprising a high concentration of anti-IL17 antibody and pharmaceutically acceptable excipients selected from the group comprising of buffer(s), stabilizer(s), viscosity modifier(s), antioxidants and surfactant(s).
Disclaimer: Curated by HT Syndication.
